-+ 0.00%
-+ 0.00%
-+ 0.00%

RIGEL ANNOUNCES ORAL PRESENTATION OF PHASE 1B DATA FOR R289 IN PATIENTS WITH LOWER-RISK MDS AT THE 68TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING AND EXPOSITION

Reuters·11/04/2026 14:15:01

Please log in to view news